INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

The following table sets forth the gross carrying amount and accumulated amortization of our intangible assets as of March 31, 2014 and December 31, 2013:

	March 31, 2014
	Gross Carrying Amount		Accumulated Amortization			Net Amount		Weighted- Average Amortization Period (yrs.)
Amortizing intangible assets:
OPERA® software patent	$	31,951	$	(999	)	$	30,952		15.5
Development costs of
corporate website		91,743		(91,743	)		—		n/a
Approved hormone
therapy drug
candidate patents		255,649		(3,364	)		252,285		18.75
Non-amortizing intangible
assets:
Hormone therapy drug
candidate patents (pending)		412,406		—			412,406		n/a
Multiple trademarks for
vitamins/supplements		61,283		—			61,283		n/a
Total	$	853,032	$	(96,106	)	$	756,926

	December 31, 2013
	Gross Carrying Amount		Accumulated Amortization			Net Amount		Weighted- Average Amortization Period (yrs.)
Amortizing intangible assets:
OPERA® software patent	$	31,951	$	(499	)	$	31,452		15.8
Development costs of corporate website		91,743		(89,661	)		2,082		0.3
Non-amortizing intangible assets:
Hormone therapy drug candidate patents (pending)		572,726		—			572,726		n/a
Multiple trademarks for vitamins/supplements		59,328		—			59,328		n/a
Total	$	755,748	$	(90,160	)	$	665,588

Schedule of estimated amortization expense

Amortization expense was $5,946 and $3,254 for the three months ended March 31, 2014 and 2013, respectively. Estimated amortization expense for the next five years is as follows:

Year Ending December 31,		Estimated Amortization
	2014 (9 months)	$	11,589
	2015	$	15,452
	2016	$	15,452
	2017	$	15,452
	2018	$	15,452